Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001072613-16-000842
Filing Date
2016-06-28
Accepted
2016-06-28 13:03:10
Documents
1
Group Members
ATP III GP, LTD.BRAEBURN PHARMACEUTICALS, INC.SETH L. HARRISON

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D - AMEND. 3 titan-sch13d_17962.htm SC 13D/A 39682
  Complete submission text file 0001072613-16-000842.txt   41350
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-46083 | Film No.: 161735486
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 47 HULFISH STREET SUITE 441 PRINCETON NJ 08542
Business Address 47 HULFISH STREET SUITE 441 PRINCETON NJ 08542 609-751-5375
Apple Tree Partners IV, L.P. (Filed by) CIK: 0001593440 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A